TITLE

A gene transcription signature associated with hormone independence in a subset of both breast and prostate cancers

AUTHOR(S)
Creighton, Chad J
PUB. DATE
January 2007
SOURCE
BMC Genomics;2007, Vol. 8, p199
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: The development of resistance to hormone therapy in both breast and prostate cancers is attributed to tens of thousands of patient deaths every year. Results: From analyses of global gene expression profile data, a nonrandom amount of overlap was observed between the set of genes associated with estrogen receptor negative (ER-), hormone independent breast cancer and the set of genes associated with androgen independent (AI) prostate cancer. A set of 81 genes was identified that were differentially expressed between ER- and ER+ clinical breast tumors and breast cancer cell lines and that showed concordant expression in AI versus AS (androgen sensitive) prostate cell lines. This common gene signature of hormone independence was used to identify a subset of clinically localized primary prostate tumors that shared extensive similarities in gene transcription with both ER- breast and AI prostate cell lines and that tended to show concurrent deactivation of the androgen signaling pathway. Both ER-breast and AI prostate cell lines were significantly enriched for transcriptional targets of signaling via epidermal growth factor receptor (EGFR). Conclusion: This study indicates that the growth- and survival-promoting functions of hormone receptors can be bypassed in a subset of both breast and prostate cancers by the same growth factor signaling pathways, which holds implications for the use of targeted therapy regimens.
ACCESSION #
28858854

 

Related Articles

  • DNA Methylation and the HOXC6 Paradox in Prostate Cancer. Vinarskaja, Anna; Yamanaka, Masanori; Ingenwerth, Marc; Schulz, Wolfgang A. // Cancers;2011, Vol. 3 Issue 4, p3714 

    Overexpression of the classical homeobox transcription factor HOXC6 is frequent in prostate cancers and correlates with adverse clinical parameters. Since surprisingly many HOXC6 target genes are downregulated in prostate cancer, it has been posited that oncogenic effects of HOXC6 in prostate...

  • Anti-tumor effect of RGD modified PTX loaded liposome on prostatic cancer. Yunjie Cao; Yaojun Zhou; Qianfeng Zhuang; Li Cui; Xianlin Xu; Renfang Xu; Xiaozhou He // International Journal of Clinical & Experimental Medicine;2015, Vol. 8 Issue 8, p12182 

    In this study, we report an active targeting liposomal formulation directed by a novel peptide (RGD) that specifically binds to the integrins receptors overexpressed on prostatic cancer cells. The objectives of this study were to evaluate the in vitro and in vivo tumor drug targeting delivery of...

  • Epidermal growth factor potentiates in vitro metastatic behaviour of human prostate cancer PC-3M cells: involvement of voltage-gated sodium channel. Uysal-Onganer, Pinar; Djamgoz, Mustafa B. A. // Molecular Cancer;2007, Vol. 6, p76 

    Background: Although a high level of functional voltage-gated sodium channel (VGSC) expression has been found in strongly metastatic human and rat prostate cancer (PCa) cells, the mechanism(s) responsible for the upregulation is unknown. The concentration of epidermal growth factor (EGF), a...

  • Differential Impact of EGFR-Targeted Therapies on Hypoxia Responses: Implications for Treatment Sensitivity in Triple-Negative Metastatic Breast Cancer. Guerrab, Abderrahim El; Zegrour, Rabah; Nemlin, Carine-Christiane; Vigier, Flavie; Cayre, Anne; Penault-Llorca, Frederique; Rossignol, Fabrice; Bignon, Yves-Jean // PLoS ONE;2011, Vol. 6 Issue 9, p1 

    Background: In solid tumors, such as breast cancer, cells are exposed to hypoxia. Cancer cells adapt their metabolism by activating hypoxia-inducible factors (HIFs) that promote the transcription of genes involved in processes such as cell survival, drug resistance and metastasis. HIF-1 is also...

  • Genome-Wide Analysis Reveals PADI4 Cooperates with Elk-1 to Activate c-Fos Expression in Breast Cancer Cells. Xuesen Zhang; Gamble, Matthew J.; Stadler, Sonja; Cherrington, Brian D.; Causey, Corey P.; Thompson, Paul R.; Roberson, Mark S.; Kraus, W. Lee; Coonrod, Scott A. // PLoS Genetics;Jun2011, Vol. 7 Issue 6, Special section p1 

    Peptidylarginine deiminase IV (PADI4) catalyzes the conversion of positively charged arginine and methylarginine residues to neutrally charged citrulline, and this activity has been linked to the repression of a limited number of target genes. To broaden our knowledge of the regulatory potential...

  • PBX1 Genomic Pioneer Function Drives ERα Signaling Underlying Progression in Breast Cancer. Magnani, Luca; Ballantyne, Elizabeth B.; Xiaoyang Zhang; Lupien, Mathieu // PLoS Genetics;Nov2011, Vol. 7 Issue 11, Special section p1 

    Altered transcriptional programs are a hallmark of diseases, yet how these are established is still ill-defined. PBX1 is a TALE homeodomain protein involved in the development of different types of cancers. The estrogen receptor alpha (ERα) is central to the development of two-thirds of all...

  • Breast cancer quality control. Patterson, Cam; Ronnebaum, Sarah // Nature Cell Biology;Mar2009, Vol. 11 Issue 3, p239 

    Tumorigenesis is regulated by several mechanisms including signalling, transcription and DNA replication. Now a cytoplasmic protein quality-control pathway is implicated in the suppression of breast cancer cell growth, suggesting a new role for quality-control mechanisms in suppressing cells...

  • Inhibition of Stromal PlGF Suppresses the Growth of Prostate Cancer Xenografts. Zins, Karin; Thomas, Anita; Lucas, Trevor; Sioud, Mouldy; Aharinejad, Seyedhossein; Abraham, Dietmar // International Journal of Molecular Sciences;Sep2013, Vol. 14 Issue 9, p17958 

    The growth and vascularization of prostate cancer is dependent on interactions between cancer cells and supporting stromal cells. The primary stromal cell type found in prostate tumors is the carcinoma-associated fibroblast, which produces placental growth factor (PlGF). PlGF is a member of the...

  • Hepatocyte growth factor increases the invasive potential of PC-3 human prostate cancer cells via an ERK/MAPK and Zeb-1 signaling pathway. YILI HAN; YONG LUO; YONGXING WANG; YATONG CHEN; MINGCHUAN LI; YONGGUANG JIANG // Oncology Letters;Jan2016, Vol. 11 Issue 1, p753 

    Hepatocyte growth factor (HGF) has been implicated in epithelial-mesenchymal transition (EMT) in numerous types of cancer. However, to the best of our knowledge, there has been no previous evidence that HGF has a role in prostate cancer. The present study aimed to investigate the effect of HGF...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics